Hopelab
Hopelab is a social innovation lab focused on designing science-based technologies to improve the health and well-being of teens and young adults. Founded in 2001 by Pam Omidyar, it combines research, design, and strategic partnerships to create scalable solutions aimed at some of the most challenging issues facing today's youth, including chronic illness, mental health, and social isolation.
History[edit]
Hopelab was established with the vision of leveraging technology to create positive health outcomes for young people. The organization's approach is rooted in the belief that technology, when thoughtfully designed and scientifically tested, can be a powerful tool for improving lives. Over the years, Hopelab has embarked on various projects, from developing video games that help children fighting cancer to creating digital platforms that support mental health.
Projects[edit]
One of Hopelab's notable projects is Re-Mission, a video game designed to help young cancer patients adhere to their treatment plans. The game was developed based on research showing that engaging in gameplay could significantly improve treatment adherence and health-related knowledge among young patients. Another project, Vivibot, is a chatbot designed for young cancer survivors to help them develop positive coping mechanisms and reduce feelings of isolation.
Research and Impact[edit]
Hopelab's work is characterized by a strong emphasis on research and evidence. The organization collaborates with researchers, healthcare professionals, and young people themselves to ensure that its projects are grounded in scientific evidence and meet the real needs of its target audiences. Studies have shown that Hopelab's interventions, such as Re-Mission, not only achieve their intended health outcomes but also significantly improve users' engagement and satisfaction.
Partnerships[edit]
Collaboration is key to Hopelab's approach. The organization works closely with a wide range of partners, including healthcare organizations, academic institutions, tech companies, and other nonprofits. These partnerships enable Hopelab to amplify its impact, reach more young people, and continuously innovate in the field of health technology.
Future Directions[edit]
Looking forward, Hopelab aims to expand its focus areas and explore new technologies to address emerging health challenges faced by young people. This includes increasing its work on mental health solutions, addressing the social determinants of health, and leveraging emerging technologies like artificial intelligence and virtual reality to create more personalized and effective interventions.
Hopelab gallery[edit]
-
HopeLab Logo Primary Black
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
